Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:19-25
Published online before print November 12, 2007, doi: 10.1161/HYPERTENSIONAHA.107.098186
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/1/19    most recent
HYPERTENSIONAHA.107.098186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, Z.
Right arrow Articles by Chen, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, Z.
Right arrow Articles by Chen, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Congestive
Right arrow Hypertrophy
Right arrow Oxidant stress
Right arrowRelated Article

(Hypertension. 2008;51:19.)
© 2008 American Heart Association, Inc.


Hypothesis

Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload–Induced Left Ventricular Hypertrophy and Dysfunction

Zhongbing Lu; Xin Xu; Xinli Hu; Guangshuo Zhu; Ping Zhang; Elza D. van Deel; Joel P. French; John T. Fassett; Tim D. Oury; Robert J. Bache; Yingjie Chen

From the Center for Vascular Biology (Z.L., X.X., G.Z., E.D.v.D., Y.C.) and Cardiovascular Division (Z.L., X.X., X.H., G.Z., P.Z., J.P.F., J.T.F., R.J.B., Y.C.), Department of Medicine, University of Minnesota Medical School, Minneapolis; Department of Pathology (T.D.O.), University of Pittsburgh Medical Center, University of Pittsburgh, Pa; and the Division of Experimental Cardiology (E.D.v.D.), Department of Cardiology, Cardiovascular Research School COEUR, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Correspondence to Yingjie Chen, University of Minnesota, Mayo Mail Code 508, 420 Delaware St SE, Minneapolis, MN 55455. E-mail chenx106{at}tc.umn.edu

Extracellular superoxide dismutase (SOD) contributes only a small fraction to total SOD activity in the normal heart but is strategically located to scavenge free radicals in the extracellular compartment. To examine the physiological significance of extracellular SOD in the response of the heart to hemodynamic stress, we studied the effect of extracellular SOD deficiency on transverse aortic constriction (TAC)–induced left ventricular remodeling. Under unstressed conditions extracellular SOD deficiency had no effect on myocardial total SOD activity, the ratio of glutathione:glutathione disulfide, nitrotyrosine content, or superoxide anion production but resulted in small but significant increases in myocardial fibrosis and ventricular mass. In response to TAC for 6 weeks, extracellular SOD-deficient mice developed more severe left ventricular hypertrophy (heart weight increased 2.56-fold in extracellular SOD-deficient mice as compared with 1.99-fold in wild-type mice) and pulmonary congestion (lung weight increased 2.92-fold in extracellular SOD-deficient mice as compared with 1.84-fold in wild-type mice). Extracellular SOD-deficient mice also had more ventricular fibrosis, dilation, and a greater reduction of left ventricular fractional shortening and rate of pressure development after TAC. TAC resulted in greater increases of ventricular collagen I, collagen III, matrix metalloproteinase-2, matrix metalloproteinase-9, nitrotyrosine, and superoxide anion production. TAC also resulted in a greater decrease of the ratio of glutathione:glutathione disulfide in extracellular SOD-deficient mice. The finding that extracellular SOD deficiency had minimal impact on myocardial overall SOD activity but exacerbated TAC induced myocardial oxidative stress, hypertrophy, fibrosis, and dysfunction indicates that the distribution of extracellular SOD in the extracellular space is critically important in protecting the heart against pressure overload.


Key Words: extracellular SOD • hypertrophy • congestive heart failure • oxidative stress • ventricular fibrosis • MMP


Related Article:

Sad Heart From No SOD
Maria Carolina Gongora and David G. Harrison
Hypertension 2008 51: 28-30. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M.-C. Aubin, C. Lajoie, R. Clement, H. Gosselin, A. Calderone, and L. P. Perrault
Female Rats Fed a High-Fat Diet Were Associated with Vascular Dysfunction and Cardiac Fibrosis in the Absence of Overt Obesity and Hyperlipidemia: Therapeutic Potential of Resveratrol
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 961 - 968.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Xu, J. Fassett, X. Hu, G. Zhu, Z. Lu, Y. Li, J. Schnermann, R. J. Bache, and Y. Chen
Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction
Hypertension, June 1, 2008; 51(6): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Schulz and G. Heusch
Extracellular Adenosine Attenuates Left Ventricular Hypertrophy Through Its Impact on the Protein Kinase and Phosphatase Interaction
Hypertension, June 1, 2008; 51(6): 1474 - 1475.
[Full Text] [PDF]


Home page
HypertensionHome page
M. C. Gongora and D. G. Harrison
Sad Heart From No SOD
Hypertension, January 1, 2008; 51(1): 28 - 30.
[Full Text] [PDF]